Cancer has agonized the human race for millions of years. The present decade witnesses
biological therapeutics to combat cancer effectively. Cancer Immunotherapy involves the …

Cancer is a complex pathological disease and the existing strategies for introducing
chemotherapeutic agents have restricted potential due to a lack of cancer cell targeting …

Background Important roles of INHBB in various malignancies are increasingly identified.
The underlying mechanisms in gastric cancer (GC) microenvironment are still greatly …

Luteolin (Lut) has been shown to inhibit gastric cancer (GC); however, its efficacy compared
to other clinical drugs has not been examined in human samples. This study aimed to …

Immune checkpoint blockade (ICB) therapy has revolutionized cancer treatment, but its
clinical benefit is limited in advanced gastric cancer (GC). Cancer-associated fibroblasts …

Background Cancer-associated fibroblasts (CAFs) play a pivotal role in cancer progression
and are known to mediate endocrine and chemotherapy resistance through paracrine …

Background. Acute myeloid leukemia (AML) is one of the most common hematological
malignancies and accounts for about 20% of childhood leukemias. Currently …

Abstract Immune-checkpoint inhibitors (ICIs), different from traditional cancer treatment
models, have shown unprecedented anti-tumor effects in the past decade, greatly improving …

The precise mechanism of resistance to anti-cancer drugs such as platinum drugs is not fully
revealed. To reveal the mechanism of drug resistance, the molecular networks of anti-cancer …

BACKGROUND Gastric cancer (GC) is a highly aggressive malignancy with a
heterogeneous nature, which makes prognosis prediction and treatment determination …